The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kazantseva I.A.

M.F. Vladimirsky Moscow Regional Research Clinical Institute

Lishchuk S.V.

GU "Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo"

Gribunov Iu.P.

Tsentral'naia klinicheskaia bol'nitsa s poliklinikoĭ Upravleniia delami Prezidenta RF;
kafedra khirurgii fakul'teta fundamental'noĭ meditsiny Moskovskogo gosudarstvennogo universiteta im. M.V. Lomonosova, Moskva

Shestakova I.N.

Central Clinical Hospital with Polyclinic, Department for Presidential Affairs of the Russian Federation, Moscow, Russia;
Peoples’ Friendship University of Russia, Moscow, Russia

Pavlov K.A.

ZAO «Evropejskij meditsinskij tsentr», Moskva, Rossija, 123104

Gastric cancer concurrent with IgG4-related disease: A clinical case and a review of literature

Authors:

Kazantseva I.A., Lishchuk S.V., Gribunov Iu.P., Shestakova I.N., Pavlov K.A.

More about the authors

Read: 6350 times


To cite this article:

Kazantseva IA, Lishchuk SV, Gribunov IuP, Shestakova IN, Pavlov KA. Gastric cancer concurrent with IgG4-related disease: A clinical case and a review of literature. Russian Journal of Archive of Pathology. 2016;78(4):43‑47. (In Russ.)
https://doi.org/10.17116/patol201678443-47

Recommended articles:
Claudin-18.2 and gastric cancer: from physiology to carcinogenesis. Russian Journal of Archive of Pathology. 2024;(6):92-99
The phenomenon of tumor budding in gastric cancer. Russian Journal of Archive of Pathology. 2025;(2):79-87
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139

References:

  1. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38(10):982-984.  doi:10.1007/s00535-003-1175-y
  2. Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol. 2006;41:1197-1205. doi:10.1007/s00535-006-1908-9
  3. Kazantsevа I.A., Lishchuk S.V. IgG4-related sclerosing disease. Arkhiv patologii. 2011;73(3):40-43. (In Russ.)
  4. Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64(10):3061-3067. doi:10.1002/art.34593
  5. Kazantsevа I, Lishchuk S. New systemic entity - IgG4-related sclerosing disease. Klinicheskaya i eksperimental'naya morfologiya. 2013;2(6):12-17. (In Russ.)
  6. Koizumi S, Kamisawa T, Kuruma S, Tabata T, Chiba K, Iwasaki S et al. Organ correlation in IgG4-related diseases. J Korean Med Sci. 2015;30(6):743-748.  doi:10.3346/jkms.2015.30.6.743
  7. Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181-1192. doi:10.1038/modpathol.2012.72
  8. Cheuk W, Yuen HK, Chu SY, Chiu EK, Lam LK, Chan JK. Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32(5):671-681.  doi:10.1097/PAS.0b013e318157c068
  9. Zen Y, Inoue D, Kitao A, Onodera M, Abo H, Miyayama S et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol. 2009;33(12):1886-1893. doi:10.1097/PAS.0b013e3181bd535b
  10. Geyer JT, Ferry JA, Harris NL, Stone JH, Zukerberg LR, Lauwers GY et al. Chronic sclerosing sialadenitis (Küttner tumor) is anIgG4-associated disease. Am J Surg Pathol. 2010;34(2):202-210.  doi:10.1097/PAS.0b013e3181c811ad
  11. Cheuk W, Yuen HK, Chan JK. Chronic sclerosing dacryoadenitis: part of the spectrum of IgG4-related sclerosing disease? Am J Surg Pathol. 2007;31(4):643-645.  doi:10.1097/01.pas.0000213445.08902.11
  12. Daveau M, Pavie-Fischer J, Rivat L, Rivat C, Ropartz C, Peter HH et al. IgG4 subclass in malignant melanoma. J Natl Cancer Inst. 1977;58(2):189-192.
  13. Litvak DA, Gupta RK, Yee R, Wanek LA, Ye W, Morton DL. Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors. J Am Coll Surg. 2004;198(1):27-35.  doi:10.1016/j.jamcollsurg.2003.08.012
  14. Karagiannis P, Gilbert AE, Josephs DH, Ali N, Dodev T, Saul L et al. IgG4 subclass antibodies impair antitumor immunity in melanoma. J Clin Invest. 2013;123(4):1457-1474. doi:10.1158/1538-7445.tumimm2012-b65
  15. Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34:1812-1819. doi:10.1097/pas.0b013e3181f7266b
  16. Kanda G, Ryu T, Shirai T, Ijichi M, Hishima T, Kitamura S, Bandai Y. peripheral T-cell lymphoma that developed during the follow-up of IgG4-related disease. Intern Med. 2011;50(2):155-160.  doi:10.2169/internalmedicine.50.4413
  17. Marunaka H, Orita Y, Tachibana T, Miki K, Makino T, Yoshino T et al. Diffuse large B-cell lymphoma of the lacrimal sac arising from a patient with IgG4-related disease. Mod Rheumatol. 2016;Feb.16:1-5.  doi:10.3109/14397595.2015.1131353
  18. Ohno K, Sato Y, Ohshima K, Takata K, Miyata-Takata T, Takeuchi M et al. A subset of ocular adnexal marginal zone lymphomas may arise in association with IgG4-related disease. Sci Rep. 2015;5:13539. doi:10.1038/srep13539
  19. Hirano K, Tada M, Sasahira N, Isayama H, Mizuno S, Takagi K et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med. 2014;53(3):171-176.  doi:10.1016/S0016-5085(13)61690-X
  20. Hart PA, Law RJ, Dierkhising RA, Smyrk TC, Takahashi N, Chari ST. Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas. 2014;43(3):417-421.  doi:10.1097/MPA.0000000000000053
  21. Inoue T, Hayama M, Kobayashi S, Oyaizu T, Nakazato Y, Honma K, Chida M. Lung cancer complicated with IgG4-related disease of the lung. Ann Thorac Cardiovasc Surg. 2014;20(Supp.l):474-477.  doi:10.5761/atcs.cr.12.02208
  22. Hiraoka N, Onozato K, Kosuge T, Hirohashi S. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res. 2006;12(18):5423-5434. doi:10.1158/1078-0432.ccr-06-0369
  23. Harada K, Shimoda S, Kimura Y, Sato Y, Ikeda H, Igarashi S et al. Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: molecular mechanism of IgG4 reaction in cancer tissue. Hepatology. 2012;56(1):157-164.  doi:10.1002/hep.25627
  24. Yoneda M, Inada H, Kanayama K, Shiraishi T. A case of pancreatic ductal adenocarcinoma with marked infiltration with IgG4-positive cells. J Cytol. 2013;30(1):46-48.  doi:10.4103/0970-9371.107513
  25. Shiokawa M, Kodama Y, Yoshimura K, Kawanami C, Mimura J, Yamashita Y et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013;108:610-617.  doi:10.1016/s0016-5085(12)61726-0

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.